Literature DB >> 22012009

Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis.

Elisabeth Njamkepo1, Stéphane Bonacorsi, Monique Debruyne, Sophie Anne Gibaud, Sophie Guillot, Nicole Guiso.   

Abstract

Pertussis is routinely diagnosed with real-time PCR based on insertion sequence IS481, which is not specific for Bordetella pertussis. We conducted a retrospective study using real-time PCRs specific for Bordetella pertussis and for Bordetella holmesii on 177 samples positive for IS481 PCR. Bordetella holmesii DNA was detected in 20.3% samples collected from adolescents and adults.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22012009      PMCID： PMC3233004          DOI： 10.1128/JCM.01272-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Recovery of Bordetella holmesii from patients with pertussis-like symptoms: use of pulsed-field gel electrophoresis to characterize circulating strains.

Authors:  E Mazengia; E A Silva; J A Peppe; R Timperi; H George
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Nucleic Acid amplification tests for diagnosis of Bordetella infections.

Authors:  M Riffelmann; C H Wirsing von König; V Caro; N Guiso
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Use of Bordetella pertussis BP3385 to establish a cutoff value for an IS481-targeted real-time PCR assay.

Authors:  J L Guthrie; C Seah; S Brown; P Tang; F Jamieson; S J Drews
Journal:  J Clin Microbiol       Date:  2008-09-10       Impact factor: 5.948

4.  First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.

Authors:  V Bouchez; D Brun; T Cantinelli; G Dore; E Njamkepo; N Guiso
Journal:  Vaccine       Date:  2009-08-08       Impact factor: 3.641

5.  Bordetella holmesii isolated from a patient with sickle cell anemia: analysis and comparison with other Bordetella holmesii isolates.

Authors:  E Njamkepo; F Delisle; I Hagege; G Gerbaud; N Guiso
Journal:  Clin Microbiol Infect       Date:  2000-03       Impact factor: 8.067

6.  Novel duplex real-time PCR assay detects Bordetella holmesii in specimens from patients with Pertussis-like symptoms in Ontario, Canada.

Authors:  J L Guthrie; A V Robertson; P Tang; F Jamieson; S J Drews
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

7.  Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis.

Authors:  Mia Antila; Qiushui He; Caroline de Jong; Ingrid Aarts; Harold Verbakel; Sylvia Bruisten; Suzanne Keller; Marjo Haanperä; Johanna Mäkinen; Erkki Eerola; Matti K Viljanen; Jussi Mertsola; Anneke van der Zee
Journal:  J Med Microbiol       Date:  2006-08       Impact factor: 2.472

8.  Evaluation of specificity of BP3385 for Bordetella pertussis detection.

Authors:  Karen B Register; Tracy L Nicholson; J L Guthrie
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

9.  Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007.

Authors:  Philippe André; Valerie Caro; Elisabeth Njamkepo; Aaron M Wendelboe; Annelies Van Rie; Nicole Guiso
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

10.  Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms.

Authors:  W K Yih; E A Silva; J Ida; N Harrington; S M Lett; H George
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883
  10 in total
  34 in total

1.  Multicenter Clinical Evaluation of the Automated Aries Bordetella Assay.

Authors:  Ryan F Relich; Amy Leber; Stephen Young; Ted Schutzbank; Ronald Dunn; Janet Farhang; Timothy S Uphoff
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

2.  Bordetella holmesii in nasopharyngeal samples from Chilean patients with suspected Bordetella pertussis infection.

Authors:  Carolina Miranda; Lorena Porte; Patricia García
Journal:  J Clin Microbiol       Date:  2012-04       Impact factor: 5.948

Review 3.  Towards improved accuracy of Bordetella pertussis nucleic acid amplification tests.

Authors:  Michael Loeffelholz
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

Review 4.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

5.  How to fight pertussis?

Authors:  Nicole Guiso
Journal:  Ther Adv Vaccines       Date:  2013-07

6.  Evaluation of Level of Agreement in Bordetella Species Identification in Three U.S. Laboratories during a Period of Increased Pertussis.

Authors:  Brunilís Burgos-Rivera; Adria D Lee; Katherine E Bowden; Amanda E Faulkner; Brent L Seaton; Bryndon D Lembke; Charles P Cartwright; Stacey W Martin; M Lucia Tondella
Journal:  J Clin Microbiol       Date:  2015-03-25       Impact factor: 5.948

Review 7.  Genotypic and phenotypic adaptation of pathogens: lesson from the genus Bordetella.

Authors:  Bodo Linz; Longhuan Ma; Israel Rivera; Eric T Harvill
Journal:  Curr Opin Infect Dis       Date:  2019-06       Impact factor: 4.915

8.  Follow-Up of External Quality Controls for PCR-Based Diagnosis of Whooping Cough in a Hospital Laboratory Network (Renacoq) and in Other Hospital and Private Laboratories in France.

Authors:  Sophie Guillot; Nicole Guiso
Journal:  J Clin Microbiol       Date:  2016-05-18       Impact factor: 5.948

Review 9.  Resolving pertussis immunity and vaccine effectiveness using incidence time series.

Authors:  Jennie S Lavine; Pejman Rohani
Journal:  Expert Rev Vaccines       Date:  2012-11       Impact factor: 5.217

10.  Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome.

Authors:  A Tizolova; N Guiso; S Guillot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-12       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.